Evaluation of Gastrointestinal Symptoms Following Chilean Native Beans Consumption
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
The oligosaccharide content (raffinose, stachyose, and verbascose) in legumes would be responsible for gastrointestinal symptoms (bloating, pain, meteorism), associated with its consumption. We would evaluate consumption of 3 varieties of chilean native beans, and evaluate gastrointestinal symptoms produced along with expired H2 test, to correlate this with the amount of oligosaccharide content.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2020
CompletedFirst Posted
Study publicly available on registry
January 28, 2020
CompletedStudy Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedJanuary 28, 2020
January 1, 2020
4 months
January 23, 2020
January 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gastrointestinal symptoms
We will evaluate the difference in the THE GASTROINTESTINAL SYMPTOM RATING SCALE (GSRS), with the intake of different native beans
4 months
Gastrointestinal symptoms
We will evaluate the difference in the "bristol stool chart" with the intake of different native beans
4 months
Secondary Outcomes (1)
Exhaled Hydrogen Test
4 months
Study Arms (1)
Clinical Study
EXPERIMENTAL9 visits, once a week, for bean intake (80 grams of dried beans, soaked for 12 hours, cooked in new water for 1.5 - 2 hours. This is approximately 160 grams of cooked beans). Four varieties of beans (3 native and 1 commercial) will be analyzed, which will be consumed in duplicate by participants (8 visits). A ninth visit will be made to perform a exhaled hydrogen test with raffinose (5 grams), as a positive control.
Interventions
In each visit the participant would have to: 1. Fill a survey of gastrointestinal symptoms and basal bowel movements ("THE GASTROINTESTINAL SYMPTOM RATING SCALE (GSRS)) 2. Fill a survey of food consumption 3. Bean plate intake 4. Expired hydrogen test, which consists of exhaling air in a syringe every 20 minutes for 12 times (4 hours in total). During this time the participant can do quiet activities (not physical activity). 5. Fill surveys of gastrointestinal symptoms (online or on paper), during the hydrogen test, at 12 and 24 hours (3 times). During this time (1 day before and 2 days later) the participant cannot eat other bloating foods (legumes, cauliflower, broccoli, lettuce, cabbage, artichokes, onions, topinambur and others described in the food survey).
Eligibility Criteria
You may qualify if:
- Beans consumption on a regular basis (at least once a week)
- Without obvious intolerance to beans intake
You may not qualify if:
- Clinical history of recurrent gastrointestinal discomfort
- Diagnosis of any gastrointestinal disease (gastroesophageal reflux, gastritis, irritable bowel syndrome, chronic diarrheal syndrome, etc.).
- Meeting Rome IV criteria for diagnosis of irritable bowel syndrome.
- Use of medications that affect gastrointestinal motility (omeprazole, metoclopramide, domperidone, loperamide, etc.) or antibiotics in the last month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Natalia Jaralead
- Instituto de Nutrición y Tecnología de los Alimentoscollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD Msc
Study Record Dates
First Submitted
January 23, 2020
First Posted
January 28, 2020
Study Start
April 1, 2020
Primary Completion
July 31, 2020
Study Completion
October 31, 2020
Last Updated
January 28, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- 6 month after completion of the study
- Access Criteria
- data access requests will we analyzed by the principal investigator.
De-identified data for all participants will be available